Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Open in API
Filings indexed 1,608 across all filing types
Latest filing 2021-08-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
110年7月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summarized revenue report for a company named 中化生, showing monthly and cumulative net operating revenue figures with percentage changes and explanations. It includes detailed financial data for a specific month and year (民國110年07月, which corresponds to July 2021). The content is concise but contains actual financial figures and explanations rather than just an announcement or a link to a report. The document is not a full annual or interim report but rather a periodic financial summary focusing on revenue. Given the presence of substantive financial data for a period shorter than a full fiscal year and the nature of the content, it fits best as an Interim / Quarterly Report (IR). The document length is short but contains actual financial data, so it is not a mere announcement (RPA) or regulatory filing (RNS).
2021-08-10 Chinese
110年07月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, senior management, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but contains substantive data on insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2021-08-06 Chinese
110年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current and pledged shares. It includes specific data on share counts and relationships but does not contain financial statements, earnings data, or report narratives. The content is focused on insider shareholdings and changes, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions by company directors and executives. The document length is under 5,000 characters and is a direct disclosure of insider holdings rather than an announcement or summary. Therefore, the appropriate classification is DIRS.
2021-08-06 Chinese
公告本公司累積取得有價證券資訊
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a listed company (1762 中化生) disclosing cumulative acquisition of securities information. It details the transaction dates, quantities, prices, total amounts, shareholding percentages, and related compliance information. The document is short (1140 characters) and focuses on share acquisition details by the company, which aligns with a Major Shareholding Notification. There is no indication of it being a full financial report, earnings release, or management discussion. It is not an announcement of a report publication but a direct disclosure of shareholding changes. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2021-07-20 Chinese
110年年報及股東會資料 — 2021_1762_20210524F17.pdf
Regulatory Filings
2021-07-12 Chinese
110年年報及股東會資料 — 2020_1762_20210524F04.pdf
Regulatory Filings
2021-07-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.